🚀 VC round data is live in beta, check it out!
Fluicell Valuation Multiples
Discover revenue and EBITDA valuation multiples for Fluicell and similar public comparables like GenIP, AcouSort, Nanologica, AnteoTech and more.
Fluicell Overview
About Fluicell
Fluicell AB is a Swedish life science company that conducts development in regenerative medicine and human tissue-based screening models for drug development, with a particular focus on the areas of type 1 diabetes, cardiac safety screening models, and kidney diseases. The company's platform for the production of human tissue that is based on Fluicell's technology for high-resolution 3D bioprinting, and which enables the creation of tissue-based products for use in drug development and regenerative medicine.
Founded
2012
HQ
Employees
12
Website
Sectors
Financials (FY)
Market Cap
$2M
Fluicell Financials
Fluicell reported last fiscal year revenue of $655K and negative EBITDA of ($857K).
In the same fiscal year, Fluicell generated $1M in gross profit, ($857K) in EBITDA losses, and had net loss of ($910K).
Fluicell P&L
In the most recent fiscal year, Fluicell reported revenue of $655K and EBITDA of ($857K).
Fluicell expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $655K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $1M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 219% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($857K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (131%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (140%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($910K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (139%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Fluicell Stock Performance
Fluicell has current market cap of $2M.
Market Cap Evolution
Fluicell's stock price is $1.54.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $2M | 0.3% | XXX | XXX | XXX | $-0.66 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFluicell Valuation Multiples
Fluicell trades at (0.4x) EV/Revenue multiple, and 0.3x EV/EBITDA.
Fluicell Financial Valuation Multiples
As of April 19, 2026, Fluicell has market cap of $2M.
Equity research analysts estimate Fluicell's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Fluicell has a P/E ratio of (2.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | ($253K) | XXX | ($253K) | XXX | XXX | XXX |
| EV/Revenue | — | XXX | (0.4x) | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 0.3x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (0.2x) | XXX | XXX | XXX |
| P/E | — | XXX | (2.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 0.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Fluicell Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Fluicell Margins & Growth Rates
Fluicell's revenue in the last fiscal year grew by 223%.
Fluicell's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Fluicell Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 223% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (131%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (48%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 359% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Fluicell Public Comps
See public comps and valuation multiples for other Life Sciences Tools comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Fluicell | XXX | XXX | XXX | XXX | XXX | XXX |
| GenIP | XXX | XXX | XXX | XXX | XXX | XXX |
| AcouSort | XXX | XXX | XXX | XXX | XXX | XXX |
| Nanologica | XXX | XXX | XXX | XXX | XXX | XXX |
| AnteoTech | XXX | XXX | XXX | XXX | XXX | XXX |
| Harvard Apparatus | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fluicell M&A Activity
Fluicell acquired XXX companies to date.
Last acquisition by Fluicell was on XXXXXXXX, XXXXX. Fluicell acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Fluicell
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFluicell Investment Activity
Fluicell invested in XXX companies to date.
Fluicell made its latest investment on XXXXXXXX, XXXXX. Fluicell invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Fluicell
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Fluicell
| When was Fluicell founded? | Fluicell was founded in 2012. |
| Where is Fluicell headquartered? | Fluicell is headquartered in Sweden. |
| How many employees does Fluicell have? | As of today, Fluicell has over 12 employees. |
| Is Fluicell publicly listed? | Yes, Fluicell is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Fluicell? | Fluicell trades under FLUI ticker. |
| When did Fluicell go public? | Fluicell went public in 2018. |
| Who are competitors of Fluicell? | Fluicell main competitors are GenIP, AcouSort, Nanologica, AnteoTech. |
| What is the current market cap of Fluicell? | Fluicell's current market cap is $2M. |
| What is the current revenue of Fluicell? | Fluicell's last fiscal year revenue is $655K. |
| What is the current EV/Revenue multiple of Fluicell? | Current revenue multiple of Fluicell is (0.4x). |
| Is Fluicell profitable? | No, Fluicell is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.